Linked Life Data

21430561

Source:http://linkedlifedata.com/resource/pubmed/id/21430561

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2011-4-8
pubmed:abstractText
Clinical trials using cholesteryl ester transfer protein (CETP) inhibitors to raise high-density lipoprotein cholesterol (HDL-C) concentrations reported an 'off-target' blood pressure (BP) raising effect. We evaluated the relations of baseline plasma CETP activity and longitudinal BP change.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1473-5598
pubmed:author
pubmed:copyrightInfo
© 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins
pubmed:issnType
Electronic
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
863-8
pubmed:dateRevised
2011-10-31
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Circulating plasma cholesteryl ester transfer protein activity and blood pressure tracking in the community.
pubmed:affiliation
Framingham Heart Study, Framingham, MA 01702-5803, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural